PALIPALISADE BIO, INC.

Nasdaq palisadebio.com


$ 6.15 $ -0.49 (-7.3 %)    

Monday, 13-May-2024 15:51:26 EDT
QQQ $ 442.84 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 6.22
$ 6.54
$ 0.00 x 0
$ 0.00 x 0
$ 6.15 - $ 6.54
$ 3.82 - $ 36.60
22,205
na
4.78M
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-22-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-17-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-23-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-22-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-27-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-22-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-23-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-14-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 03-16-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 maxim-group-reiterates-buy-on-palisade-bio-maintains-225-price-target

Maxim Group analyst Naz Rahman reiterates Palisade Bio (NASDAQ:PALI) with a Buy and maintains $22.5 price target.

Core News & Articles
Market-Moving News for May 1 st
05/01/2024 12:44:43

TGTX: 31% | TG Therapeutics shares are trading higher following a Q1 revenue beat and increased 2024 Briumvi US net product rev...

Core News & Articles
Market-Moving News for May 1st
05/01/2024 12:41:28

TGTX: 31% | TG Therapeutics shares are trading higher following a Q1 revenue beat and increased 2024 Briumvi US net product rev...

 why-palisade-bio-stock-is-up-today

Palisade Bio entered into a collaboration with Strand Life Sciences is aimed at advancing precision medicine for ulcerative col...

 sp-500-edges-lower-pacbio-shares-plunge

U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling around 0.3% on Tuesday. The Dow traded up 0.0...

 why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...

 maxim-group-maintains-buy-on-palisade-bio-adjusts-price-target-to-225-reverse-stock-split-115

Maxim Group analyst Naz Rahman maintains Palisade Bio (NASDAQ:PALI) with a Buy, adjusts target to $22.5 from $22.5 (reverse ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION